ID

13693

Description

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis; ODM derived from: https://clinicaltrials.gov/show/NCT01461616

Link

https://clinicaltrials.gov/show/NCT01461616

Keywords

  1. 2/28/16 2/28/16 -
Uploaded on

February 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 1 NCT01461616

Eligibility Diabetes Mellitus, Type 1 NCT01461616

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. informed consent obtained before any trial-related activities.
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. diagnosis of diabetes mellitus according to who criteria; history and clinical course consistent with type 1 diabetes mellitus.
Description

diabetes mellitus type 1

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
3. diagnosed with diabetes for more than 6 years and using continuous subcutaneous insulin infusion (csii) at least 6 months at time of inclusion.
Description

continuous subcutaneous insulin infusion

Data type

boolean

Alias
UMLS CUI [1]
C0393124
4. total daily insulin dose between 0.4 and 1.4 units/kg (both values included)
Description

Dosage insulin

Data type

boolean

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0021641
5. hba1c between 6% and 9% (both values included).
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
6. age ≥ 18 years.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
7. bmi between 18.5 and 28 kg /m2 (including both values).
Description

bmi

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. known or suspected allergy to trial product(s) or related products.
Description

hypersensitivity study drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
2. recurrent major hypoglycaemic episodes.
Description

hypoglycaemic episode

Data type

boolean

Alias
UMLS CUI [1]
C0745153
3. heart: unstable angina pectoris, ami < 12 months or heart insufficiency classified according to nyha iii-iv
Description

unstable angina pectoris; nyha classification

Data type

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2]
C1275491
4. blood pressure: severe uncontrolled hypertension with bp > 180/110 mmhg, sitting
Description

blood pressure; uncontrolled hypertension

Data type

boolean

Alias
UMLS CUI [1]
C0005823
UMLS CUI [2]
C1868885
5. liver: impaired hepatic function corresponding to serum-alat or basic phosphatase > 2 x upper reference limit of the local laboratory.
Description

Liver Dysfunction; serum alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1883008
6. kidneys: impaired renal function corresponding to serum-creatinin > 150 μmol/l according to the local laboratory.
Description

renal dysfunction; serum-creatinine

Data type

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0201976
7. any disease judged by the investigator to affect the trial.
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
8. pregnancy, breast-feeding or the intention of becoming pregnant or fertile women not using adequate contraceptive measures - adequate contraceptive method is sterilisation, hysterectomy or current use of contraceptive pills or intra uterine device.
Description

Contraception status; hysterectomy

Data type

boolean

Alias
UMLS CUI [1]
C0420837
UMLS CUI [2]
C0020699

Similar models

Eligibility Diabetes Mellitus, Type 1 NCT01461616

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
1. informed consent obtained before any trial-related activities.
boolean
C0021430 (UMLS CUI [1])
diabetes mellitus type 1
Item
2. diagnosis of diabetes mellitus according to who criteria; history and clinical course consistent with type 1 diabetes mellitus.
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
continuous subcutaneous insulin infusion
Item
3. diagnosed with diabetes for more than 6 years and using continuous subcutaneous insulin infusion (csii) at least 6 months at time of inclusion.
boolean
C0393124 (UMLS CUI [1])
Dosage insulin
Item
4. total daily insulin dose between 0.4 and 1.4 units/kg (both values included)
boolean
C0178602 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
hba1c
Item
5. hba1c between 6% and 9% (both values included).
boolean
C0019018 (UMLS CUI [1])
age
Item
6. age ≥ 18 years.
boolean
C0001779 (UMLS CUI [1])
bmi
Item
7. bmi between 18.5 and 28 kg /m2 (including both values).
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hypersensitivity study drugs
Item
1. known or suspected allergy to trial product(s) or related products.
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
hypoglycaemic episode
Item
2. recurrent major hypoglycaemic episodes.
boolean
C0745153 (UMLS CUI [1])
unstable angina pectoris; nyha classification
Item
3. heart: unstable angina pectoris, ami < 12 months or heart insufficiency classified according to nyha iii-iv
boolean
C0002965 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
blood pressure; uncontrolled hypertension
Item
4. blood pressure: severe uncontrolled hypertension with bp > 180/110 mmhg, sitting
boolean
C0005823 (UMLS CUI [1])
C1868885 (UMLS CUI [2])
Liver Dysfunction; serum alanine aminotransferase measurement
Item
5. liver: impaired hepatic function corresponding to serum-alat or basic phosphatase > 2 x upper reference limit of the local laboratory.
boolean
C0086565 (UMLS CUI [1])
C1883008 (UMLS CUI [2])
renal dysfunction; serum-creatinine
Item
6. kidneys: impaired renal function corresponding to serum-creatinin > 150 μmol/l according to the local laboratory.
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Compliance behavior Limited Comorbidity
Item
7. any disease judged by the investigator to affect the trial.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Contraception status; hysterectomy
Item
8. pregnancy, breast-feeding or the intention of becoming pregnant or fertile women not using adequate contraceptive measures - adequate contraceptive method is sterilisation, hysterectomy or current use of contraceptive pills or intra uterine device.
boolean
C0420837 (UMLS CUI [1])
C0020699 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial